Teresa De Marco


Director of Advanced Heart Failure and Pulmonary Hypertension
Medical Director of Heart Transplantation

About me

Dr. Teresa De Marco is director of advanced heart failure and pulmonary hypertension for UCSF, as well as medical director of heart transplantation. She manages patients with advanced heart failure and pulmonary hypertension, with expertise in all treatment modalities for the conditions.

In her research, De Marco participates in multicenter studies evaluating state-of-the-art options for advanced stages of heart failure and pulmonary hypertension.

De Marco earned her medical degree at the University of California, Irvine, after graduating from the University of California, Berkeley. She completed both an internship and a residency in internal medicine at UCSF Medical Center. She also completed fellowships in cardiology and heart transplantation.

  • Education

    UC Irvine School of Medicine, 1982

  • Residencies

    UCSF Medical Center, Internal Medicine, 1985

  • Fellowship

    UCSF Medical Center, Heart Failure, 1987

    UCSF Medical Center, Cardiovascular Disease, 1989

  • Board Certifications

    Cardiovascular Disease, American Board of Internal Medicine/Cardiovascular Disease

    Advanced Heart Failure & Trans, American Board of Internal Medicine

    Internal Medicine, American Board of Internal Medicine

  • Academic Title


  • Languages



Advanced Heart Failure Evaluation and Therapies Program

400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143

Cardiovascular Genetics Program

535 Mission Bay Blvd. South
San Francisco, CA 94158

Heart Transplant Program

400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143

HHT Center of Excellence

185 Berry St., Suite 180, Lobby 6
San Francisco, CA 94107

Mechanical Circulatory Support

400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143

Pulmonary Hypertension Clinic

400 Parnassus Ave., Plaza Level
San Francisco, CA 94143

San Mateo Primary and Specialty Care

1100 Park Place, Suite 100
San Mateo, CA 94403

Decorative Caduceus

Pulmonary Hypertension Association Registry

The PHA Registry (PHAR) is a national study about people who have pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). PHAR collects information from people with PAH and CT...


Decorative Caduceus

Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy

Open label study to evaluate tafamidis for the treatment of transthyretin cardiomyopathy


Decorative Caduceus

Prospective Assessment of Premature Ventricular Contractions Suppression in Cardiomyopathy(PAPS...

Premature ventricular contractions (PVCs) coexist in patients with heart failure (HF) and LV dysfunction. Frequent PVCs have shown to induce a reversible cardiomyopathy (PVC-CM). This clinical pilot study will enro...


Decorative Caduceus

TReatment of Pulmonary Hypertension Group II Study

The objective of this study is to assess the safety and initial effectiveness of the TIVUS™ System when used for pulmonary artery denervation in group II PH patients through change in clinical parameters including he...